Arjo Executive and Leadership Team

Christopher Dorsey, the President (US) at Arjo, directs all commercial activities and strategic initiatives within the United States market. Overseeing the distribution of medical devices and mobility solutions, the President (US) ensures that healthcare facilities receive high-quality equipment to support patients with reduced mobility. This leadership role involves managing complex supply chains and fostering relationships with clinical partners to improve patient outcomes. By optimizing regional sales performance, Christopher Dorsey directly impacts the company's growth trajectory in the competitive American healthcare sector. Dorsey maintains a focus on operational efficiency and regulatory compliance, ensuring that all product deployments meet stringent safety standards. Through the implementation of targeted market strategies, the President (US) drives the adoption of innovative medical technologies, ultimately strengthening the market position of the organization across the entire country while supporting the broader mission of improving quality of life for aging populations.

Anne Sigouin, the President (North America) at Arjo, manages the overarching business operations and strategic growth across the North American continent. Directing cross-functional teams, the President (North America) aligns regional service delivery with the global mission of providing advanced medical solutions for mobility-impaired individuals. This role requires constant collaboration with executive leadership to refine market penetration strategies and enhance the accessibility of medical devices. By overseeing large-scale operational initiatives, Anne Sigouin ensures that the company maintains a competitive edge in the healthcare manufacturing landscape. Sigouin prioritizes the integration of new service models that address age-related health challenges, thereby increasing the value provided to clinical institutions. Through the management of regional resources and the execution of long-term business plans, the President (North America) secures sustainable revenue growth and operational excellence, consistently driving the organization toward its goal of becoming the premier provider of mobility solutions in the North American market.

Chander Tahiliani, the President, & Middle (South, Asia, East) at Arjo, architects the expansion and operational framework for diverse markets across South Asia and the Middle East. Overseeing the deployment of medical devices in these rapidly evolving regions, the President, & Middle (South, Asia, East) ensures that local healthcare providers gain access to essential mobility solutions. This leadership role involves navigating complex regulatory environments and adapting global product offerings to meet specific regional health needs. By driving strategic partnerships and managing local distribution networks, Chander Tahiliani directly influences the company's footprint in emerging markets. Tahiliani focuses on scaling operations to meet the rising demand for age-related health services, ensuring that the organization remains a trusted partner for medical facilities. Through the consistent application of high-level management practices, the President, & Middle (South, Asia, East) fosters sustainable growth and operational stability, effectively bridging the gap between global medical innovation and the specific requirements of patients in these critical geographic areas.

Ikuro Yoshizumi, the President at Arjo, provides high-level corporate leadership and defines the overarching strategic vision for the global organization. Overseeing the integration of medical device manufacturing and service delivery, the President ensures that all business units remain aligned with the core mission of improving quality of life for people with reduced mobility. This role involves constant interaction with the Board and other C-suite leaders to evaluate market trends and drive long-term innovation. By setting the tone for corporate culture and operational excellence, Ikuro Yoshizumi directly impacts the company's ability to address age-related health challenges on a global scale. Yoshizumi manages the allocation of capital and resources to support research and development, ensuring that the company remains at the forefront of medical technology. Through the execution of comprehensive growth strategies, the President secures the financial health and market leadership of the organization, consistently delivering value to stakeholders while advancing the global standard of care.